Dr. Diane Hollenbaugh is a drug discovery scientist and executive with more than 25 years of experience in biologicals research, research management, and discovery and early development with a focus on immunology and oncology. Most recently, she was Executive Director, Immuno-oncology Discovery at AbbVie where she oversaw the growth of IO efforts, including early discovery and translational science, licensing partnerships, and five discovery projects brought to IND. Prior to AbbVie, she has experience at multiple large and small companies, including BMS, Medarex, FivePrime Therapeutics and Schering-Plough/Merck.
She received a BS in Chemistry from the University of Washington, a PhD from the California Institute of Technology Division of Chemistry and Chemical Engineering, and completed her post-doc training at the Bristol-Myers Squibb Pharmaceutical Research Institute. She is an inventor on more than 20 issued patents and has authored more than 50 publications.